Press release
Investigation for Long-Term Investors in shares of Lipocine Inc. (NASDAQ: LPCN) announced
An investigation on behalf of current long term investors in Lipocine Inc. (NASDAQ: LPCN) shares.
Investors who are current long term investors in Lipocine Inc. (NASDAQ: LPCN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPCN stocks follows a lawsuit filed against Lipocine Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: LPCN stocks, concerns whether certain Lipocine directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the District of Utah the plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that the results from Lipocine's clinical studies of TLANDO were insufficient to demonstrate the drug's efficacy, that accordingly, Lipocine's third NDA for TLANDO was highly likely to be found deficient by the FDA, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Lipocine Inc. (NASDAQ: LPCN) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation for Long-Term Investors in shares of Lipocine Inc. (NASDAQ: LPCN) announced here
News-ID: 1982414 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Lipocine
Sarcopenia Market Insights Highlight Expanding Outlook Till 2034, DelveInsight E …
The Key Sarcopenia Companies in the market inlcude- TNF Pharmaceuticals, Lipocine, Biophytis, ImmunoForge, Rejuvenate Biomed, Keros Therapeutics, BPGbio, Oncocross, Mirscience Therapeutics, Turn Biotechnologies, NMD PHARMA, ImmunoForge, Dong Wha PHARM, and others.
DelveInsight's "Sarcopenia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Sarcopenia, historical and forecasted epidemiology as well as the Sarcopenia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and…
Sarcopenia Market Positioned for Accelerated Development Through 2034, DelveInsi …
The Key Sarcopenia Companies in the market include - TNF Pharmaceuticals, Lipocine, Biophytis, ImmunoForge, Rejuvenate Biomed, Keros Therapeutics, BPGbio, Oncocross, Mirscience Therapeutics, Turn Biotechnologies, NMD PHARMA, ImmunoForge, Dong Wha PHARM, and others.
DelveInsight's "Sarcopenia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Sarcopenia, historical and forecasted epidemiology as well as the Sarcopenia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom…
Postpartum Depression Clinical Trials, Companies, Therapeutic Assessment, Therap …
DelveInsight's, "Postpartum Depression - Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Postpartum Depression pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight's analysis reveals that the Postpartum Depression pipeline includes over…
Postpartum Depression Drugs Market Size Report 2034 | Pfizer, Sage Therapeutics, …
DelveInsight's "Postpartum Depression Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Postpartum Depression, historical and forecasted epidemiology as well as the Postpartum Depression market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
Explore the intricate details of the Postpartum Depression Market: Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive Postpartum Depression Market Forecast. Click here to…
Complete analysis report of Topical Contraceptive Market with projected growth | …
Global Topical Contraceptive Market 2019-2026: Snapshot
The Market Research Topical Contraceptive report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global Topical Contraceptive market based on various segments. It also provides market size and forecast estimates from the year 2017 to 2026 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa…
Deadline on January 14th in Lawsuit for Investors in Lipocine Inc. (NASDAQ: LPCN …
The Shareholders Foundation announced that a deadline is coming up on January 14, 2020 in the lawsuit filed for certain investors of Lipocine Inc. (NASDAQ: LPCN) over alleged securities laws violations by Lipocine Inc.
Investors who purchased shares of Lipocine Inc. (NASDAQ: LPCN) have certain options and there are strict and short deadlines running. Deadline: January 14, 2020. NASDAQ: LPCN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
